Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

1.1K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

814
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
814
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

755
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
755
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

701
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
701

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elevated Spleen Tyrosine Kinase in Low-Density Neutrophils During Bacterial Sepsis in a Nonhuman Primate Model.

The Journal of infectious diseases·2025
Same author

Biomimetic, Suturable, and Extensible Electrospun Scaffolds for Lower Urinary Tract Surgical Reconstruction.

Advanced healthcare materials·2025
Same author

<i>Klebsiella pneumoniae</i> induces dose-dependent shock, organ dysfunction, and coagulopathy in a nonhuman primate critical care model.

mBio·2024
Same author

Improving Outcomes in Mechanically Ventilated Adult ICU Patients Following Implementation of the ICU Liberation (ABCDEF) Bundle Across a Large Healthcare System.

Critical care explorations·2024
Same author

Clinical and Immunologic Correlates of Vasodilatory Shock Among Ebola Virus-Infected Nonhuman Primates in a Critical Care Model.

The Journal of infectious diseases·2023
Same author

Beyond the rubicon: a continuum approach to investigating the impact of ADHD like characteristics on everyday executive function in children with Tourette Syndrome.

Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence·2023

Related Experiment Video

Updated: Mar 5, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

Improving Glycemic Control Safely in Non-Critical Care Patients: A Collaborative Systems Approach in Nine Hospitals.

Gregory A Maynard, Diana Childers, Janet Holdych

    Joint Commission Journal on Quality and Patient Safety
    |March 23, 2017
    PubMed
    Summary

    Nine hospitals improved glycemic control and reduced hyperglycemia through a collaborative insulin management program. This initiative enhanced patient safety by maintaining low rates of hypoglycemia.

    More Related Videos

    A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
    10:03

    A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

    Published on: February 28, 2013

    26.7K
    Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
    07:35

    Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

    Published on: January 26, 2024

    2.3K

    Related Experiment Videos

    Last Updated: Mar 5, 2026

    Improving IV Insulin Administration in a Community Hospital
    12:08

    Improving IV Insulin Administration in a Community Hospital

    Published on: June 11, 2012

    19.5K
    A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
    10:03

    A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

    Published on: February 28, 2013

    26.7K
    Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
    07:35

    Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

    Published on: January 26, 2024

    2.3K

    Area of Science:

    • Hospital Quality Improvement
    • Endocrinology
    • Patient Safety

    Background:

    • Practice variations in insulin management and glycemic adverse events prompted a nine-hospital collaboration.
    • The initiative aimed to reduce hypoglycemia, uncontrolled hyperglycemia, and improve overall glycemic control.

    Purpose of the Study:

    • To implement and assess a collaborative effort to improve insulin management and glycemic control across multiple hospitals.
    • To reduce rates of hypoglycemia and hyperglycemia in non-critical care adult inpatients.

    Main Methods:

    • Included non-critical care adult inpatients with at least four point-of-care blood glucose readings over two days.
    • Implemented standardized insulin management and hypoglycemia prevention protocols, including order sets, education, expert mentoring, and performance feedback.
    • Utilized a 'measure-vention' approach, linking patient data monitoring with concurrent interventions to address care lapses.

    Main Results:

    • Achieved an 11.4 mg/dL improvement in the day-weighted mean blood glucose for the cohort across all nine sites.
    • Reduced severe hyperglycemic days, with the percentage of patient-days with blood glucose >299 mg/dL decreasing from 11.6% to 8.8%.
    • Eight sites reduced hypoglycemia by 20% or met top-quartile performance benchmarks, while overall hypoglycemia rates remained stable at 3.6%.

    Conclusions:

    • Multihospital improvements in glycemic control and severe hyperglycemia are achievable.
    • Low-cost toolkits and metrics can effectively enhance glycemic management and patient safety.
    • Collaborative efforts can lead to significant positive outcomes in hospital-based diabetes care.